Inoviq Ltd ( (AU:IIQ) ) just unveiled an update.
INOVIQ Limited announced that its CEO, Dr. Leearne Hinch, will present at the ShareCafe Small Cap ‘Sip and Learn’ Webinar on March 19, 2025. This presentation is part of INOVIQ’s efforts to engage with investors and stakeholders, potentially impacting the company’s visibility and positioning within the biotechnology industry.
More about Inoviq Ltd
INOVIQ Ltd is a biotechnology company focused on pioneering next-generation diagnostics and therapeutics for cancer. The company has commercialized its EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test for bladder cancer. INOVIQ is also advancing diagnostics for ovarian and breast cancers and developing early-stage exosome therapeutics for solid tumors.
YTD Price Performance: -28.85%
Average Trading Volume: 120,700
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$39.59M
See more insights into IIQ stock on TipRanks’ Stock Analysis page.